Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-23T18:43:29.595Z Has data issue: false hasContentIssue false
  • English
  • Français

CJEM and pharmaceutical advertisements: it's time for an end

Published online by Cambridge University Press:  21 May 2015

Joel Lexchin
Joel Lexchin*
Affiliation:
School of Health Policy and Management, York University, Toronto, Ont.; Emergency Department, University Health Network, Toronto, Ont.; Department of Family and Community Medicine, University of Toronto, Toronto, Ont.
*
School of Health Policy and Management, York University, 4700 Keele St., Toronto ON M3J 1P3; jlexchin@yorku.ca

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

journal advertisingpharmaceutical industryprescribingrevenue
Type
Editorial
Information
Canadian Journal of Emergency Medicine , Volume 11 , Issue 4 , July 2009 , pp. 375 - 379
Copyright
Copyright © Canadian Association of Emergency Physicians 2009

References

REFERENCES

1. Wilkes, MS, Doblin, BH, Shapiro, MF. Pharmaceutical advertisements in leading medical journals: experts’ assessments. Ann Intern Med 1992;116:912-9.CrossRefGoogle ScholarPubMed
2. Cooper, RJ, Schriger, DL, Wallace, RC, et al. Graphics in pharmaceutical advertisements: Are they truthful, are they adequately detailed? Plenary session at the Fourth International Congress on Peer Review in Biomedical Publication; 2001 Sep. 14-16; Barcelona (Spain): JAMA and BMJ Publishing Group; 2001. Available: http://www.ama-assn.org/public/peer/prc_program2001.htm#truthful (accessed 2009 May 15).Google Scholar
3. Lexchin, J. How patient outcomes are reported in drug advertisements: review of Canadian medical journals. Can Fam Physician 1999;45:1213-6.Google Scholar
4. Loke, TW, Koh, FC, Ward, JE. Pharmaceutical advertisement claims in Australian medical publications: Is evidence accessible, compelling and communicated comprehensively? Med J Aust 2002;177:291-3.Google Scholar
5. Gutknecht, DR. Evidence-based advertising? A survey of four major journals. J Am Board Fam Pract 2001;14:197-200.Google Scholar
6. Lankinen, KS, Levola, T, Marttinen, K, et al. Industry guidelines, laws and regulations ignored: quality of drug advertising in medical journals. Pharmacoepidemiol Drug Saf 2004;13: 789-95.CrossRefGoogle ScholarPubMed
7. Neumann, PJ, Bambauer, KZ, Ramakrishnan, V, et al. Economic messages in prescription drug advertisements in medical journals. Med Care 2002;40:840-5.Google Scholar
8. Spielmans, GI, Thielges, SA, Dent, AL, et al. The accuracy of psychiatric medication advertisements in medical journals. J Nerv Ment Dis 2008;196:267-73.Google Scholar
9. Montgomery, BD, Mansfield, PR, Spurling, GK, et al. Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study. BMC Public Health 2008;8:167.Google Scholar
10. Cooper, RJ, Schriger, DL. The availability of references and the sponsorship of original research cited in pharmaceutical advertisements. CMAJ 2005;172:487-91.Google Scholar
11. Lexchin, J, Holbrook, A. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal. CMAJ 1994;151:47-54.Google Scholar
12. Hemeryck, L, Chan, R, McCormack, PME, et al. Pharmaceutical advertisements in Irish medical journals. J Pharm Med. 1995;5:147-51.Google Scholar
13. McGettigan, P, Golden, J, Fryer, J, et al. Prescribers prefer people: the sources of information used by doctors for prescribing suggest that the medium is more important than the message. Br J Clin Pharmacol 2001;51:184-9.Google Scholar
14. Prosser, H, Almond, S, Walley, T. Influences on GPs’ decision to prescribe new drugs — the importance of who says what. Fam Pract 2003;20:61-8.Google Scholar
15. Avorn, J, Chen, M, Hartley, R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 1982;73:4-8.Google Scholar
16. Greenwood, J. Pharmaceutical representatives and the prescribing of drugs by family doctors [dissertation]. Nottingham (UK): Nottingham University; 1989.Google Scholar
17. Findlay, S. Prescription drugs and mass media advertising. Washington (DC): National Institute for Health Care Management Research and Educational Foundation; 2000.Google Scholar
18. Bower, AD, Burkett, GL. Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes and practices. J Fam Pract 1987;24:612-6.Google Scholar
19. Ferry, ME, Lamy, PP, Becker, LA. Physicians’ knowledge of prescribing for the elderly: a study of primary care physicians in Pennsylvania. J Am Geriatr Soc 1985;33:616-21.CrossRefGoogle ScholarPubMed
20. Fletcher, RH. Adverts in medical journals: caveat lector. Lancet 2003;361:10-1.Google Scholar
21. Smith, R. Should medical journals carry drug advertising? BMJ 2007;335:74.Google Scholar
22. Glassman, PA, Hunter-Hayes, J, Nakamura, T. Pharmaceutical advertising revenue and physician organizations: How much is too much? West J Med 1999;171:234-8.Google Scholar
23. Fugh-Berman, A, Alladin, K, Chow, J. Advertising in medical journals: Should current practices change? P LoS Med 2006;3:e130.Google Scholar
24. Pharmaceutical Advertising Advisory Board. Code of advertising acceptance. Pickering (ON): The Board; 2007.Google Scholar
25. Lexchin, J, Light, D. Commercial influence and the content of medical journals. BMJ 2006;332:1444-7.CrossRefGoogle ScholarPubMed
26. Mansfield, PR, Lexchin, J, Wen, LS, et al. Educating health professionals about drug and device promotion: advocates’ recommendations. PLoS Med 2006;3:e451.Google Scholar
27. Hardin, G. The tragedy of the commons. Science 1968;162:1243-8.CrossRefGoogle ScholarPubMed